Mid-Day Breakouts Report - Tuesday, August 7th, 2012

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Monday, February 26, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - TUESDAY, AUGUST 7TH, 2012
Previous Mid Day Report Next Mid Day Report >>>

DOW 13201.68 84.17 (0.64%) | NASDAQ 3027.49 37.58 (1.26%) | S&P 500 1405.96 11.73 (0.84%)

Time of Screening : 8/7/2012 12:06:19 PM Report Released : 8/7/2012 12:45:21 PM
Price is: Above 52W High and Less Than 52W High but within 5% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Pivot Point
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Max Buy
GPX - NYSE G P Strategies Corp	$19.43	+0.05 0.26%	$19.59	60,287 97.39% of 50 DAV 50 DAV is 61,900	$20.08 -3.24%	6/29/2012	$18.01	PP = $18.15 MB = $19.06
Most Recent Note - 8/7/2012 12:25:02 PM G - After 3 consecutive volume-driven gains it is perched at its 52-week high. Color code was changed to green after rallying above its "max buy" level. Reported earnings +41% on +19% sales revenues for the Jun '12 quarter. Found support near its 50 DMA line when recently consolidating. >>> The latest Featured Stock Update with an annotated graph appeared on 7/6/2012. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
RNF - NYSE Rentech Nitrogen Ptnr Lp	$32.48	+2.08 6.84%	$32.48	359,491 98.90% of 50 DAV 50 DAV is 363,500	$32.62 -0.43%	7/27/2012	$29.58	PP = $30.60 MB = $32.13
Most Recent Note - 8/7/2012 12:38:14 PM Y - Hit a new 52-week high with today's volume-driven gain above its pivot point. A strong close above that threshold with at least +40% above average volume behind its gain may trigger a technical buy signal. >>> The latest Featured Stock Update with an annotated graph appeared on 7/31/2012. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VSI - NYSE Vitamin Shoppe Inc	$59.68	+2.97 5.24%	$61.49	480,708 135.45% of 50 DAV 50 DAV is 354,900	$61.49 -2.95%	6/29/2012	$54.93	PP = $55.03 MB = $57.78
Most Recent Note - 8/7/2012 12:41:45 PM G - Reported earnings +38% on +13% sales revenues for the quarter ended June 30, 2012 versus the year ago period. Color code was changed to green while hitting new all-time highs above its "max buy" level. Its 50 DMA line and upward trendline define near-term chart support to watch. >>> The latest Featured Stock Update with an annotated graph appeared on 8/2/2012. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
AGU - NYSE - CHEMICALS - Agricultural Chemicals Agrium Inc	$97.69	+2.45 2.57%	$97.83	$97.83	-0.14%	637,601 60.46%	1,054,600
Most Recent Note for AGU - 8/7/2012 12:08:38 PM Hit a new 52-week high today after consolidating above prior resistance in the $89 area. Reported earnings +20% on +10% sales for the Jun '12 quarter. Prior mid-day reports noted - "Recent quarters showed improving sales and earnings but its prior history is below guidelines of the fact-based investment system. Based on weak technical action it was dropped from the Featured Stocks list 7/25/08, and it subsequently dropped from $84.18 to $22.08 before rebounding."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BTI - AMEX - TOBACCO - Cigarettes British Amer Tobacco Adr	$108.90	-0.01 -0.01%	$109.29	$109.73	-0.76%	225,100 91.24%	246,700
Most Recent Note for BTI - 8/7/2012 12:09:44 PM Perched near its 52-week high. The 8/02/12 mid-day report noted - "Quarterly comparisons show sub par sales revenues and earnings increases, not a match with the fact-based system's fundamental guidelines. Its annual earnings history has been slow and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CBM - NYSE - CHEMICALS - Specialty Chemicals Cambrex Corp	$10.99	+0.11 1.01%	$11.05	$11.41	-3.68%	122,815 60.71%	202,300
Most Recent Note for CBM - 8/7/2012 12:10:28 PM Holding its ground at its 52-week high after a considerable 8/02/12 gain with above average volume. This low-priced Medical - Products firm found support near its 200 DMA line during its consolidation since last noted in the 1/18/12 mid-day report then worked its way higher in recent months with above average volume behind gains. Sales revenues and earnings improved in the Mar and Jun '12 quarters, but prior mid-day reports noted - "Annual earnings (A criteria) history has not been strong and steady. Low-priced stocks are discouraged from consideration as buy candidates under the fact-based system unless all key criteria are solidly satisfied."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CF - NYSE - CHEMICALS - Agricultural Chemicals C F Industries Holdings	$204.06	+0.60 0.29%	$206.88	$208.43	-2.10%	1,297,327 95.84%	1,353,600
Most Recent Note for CF - 8/7/2012 12:12:07 PM Perched near its 52-week high, and no resistance remains due to overhead supply. Reported earnings +25% on -4% sales revenues for the Jun '12 quarter. Rebounded after a choppy consolidation below its 200 DMA line since noted in the 4/25/12 mid-day report - "This high-ranked leader's earnings and sales revenues showed great increases in recent quarterly comparisons, however it lacks a good steady annual earnings growth history (the A criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
DVA - NYSE - HEALTH SERVICES - Specialized Health Services Davita Healthcare Prtns	$97.00	+1.27 1.33%	$97.25	$100.52	-3.50%	462,052 57.89%	798,100
Most Recent Note for DVA - 8/7/2012 12:18:12 PM Perched near its 52-week high encountering recent distributional pressure, but no overhead supply remains to act as resistance. Quarterly earnings increases have been above the +25% guideline (C criteria) and it has shown steady annual earnings growth. Ownership by top-rated funds fell from 1,009 in Dec '11 to 970 in Jun '12, a slightly disconcerting sign concerning the I criteria.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ENS - NYSE - MANUFACTURING - Industrial Electrical Equipmen Enersys	$35.24	+0.24 0.69%	$35.56	$36.58	-3.66%	215,558 61.00%	353,400
Most Recent Note for ENS - 8/7/2012 12:20:27 PM Quarterly and annual earnings history (C and A criteria) has not been strong and steady. It survived but failed to impress since noted in the 4/07/11 mid-day report and earlier reports - "Based on weak action it was dropped from the Featured Stocks list on 8/07/08. Recent quarterly comparisons show improving sales and earnings after negative comparisons and a downward turn in its FY '10 earnings (A criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
FEIC - NASDAQ - ELECTRONICS - Diversified Electronics F E I Co	$54.54	+0.45 0.83%	$54.63	$0.00	-3.66%	269,884 78.25%	344,900
Most Recent Note for FEIC - 8/7/2012 12:21:08 PM Hitting another new 52-week high with today's 4th consecutive volume-driven gain. Found support above its 200 DMA line in recent months after weak action and deteriorating fundamentals prompted it to be dropped from the Featured Stocks list on 5/15/12. Reported earnings +19% on +5% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking 3 consecutive quarters below the +25% minimum guideline for earnings growth.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GABC - NASDAQ - BANKING - Regional - Midwest Banks German American Bancorp	$21.47	+0.11 0.51%	$21.76	$21.98	-2.32%	15,282 69.78%	21,900
Most Recent Note for GABC - 8/7/2012 12:23:47 PM Reported earnings +21% on -2% sales revenues in the Jun '12 quarter, a 2nd consecutive quarter with lower sales revenues than the year ago period. Found support near its 200 DMA line during its consolidation since noted in the 2/21/12 mid-day report - "Extended from prior highs in the $18-19 area and hovering near its 52-week high, stubbornly holding its ground after a recent spurt of gains. The 3 latest quarterly earnings increases (through Dec '11) showed growth above the +25% minimum guideline, satisfying the C criteria. Its annual earnings history included a dip in FY '09."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IHG - NYSE - LEISURE - Lodging Intercontinental Hotels	$27.01	+1.75 6.93%	$27.19	$27.19	-0.66%	614,408 179.18%	342,900
Most Recent Note for IHG - 8/7/2012 12:29:51 PM Considerable gap up today for a new 52-week high. Found support near its 50 DMA line. Reported earnings +9% on +3% sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports noted - "Its prior earnings history (A criteria) is below guidelines of the fact-based system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IPGP - NASDAQ - ELECTRONICS - Semiconductor - Integrated Circuits I P G Photonics Corp	$62.01	+1.46 2.41%	$62.23	$64.45	-3.79%	714,499 110.64%	645,800
Most Recent Note for IPGP - 8/7/2012 12:31:50 PM Reported earnings +14% on +13% sales for the Jun '12 quarter. Prior mid-day reports noted - "Downturn in FY '09 earnings is a flaw with respect to the A criteria of the fact-based system. Its prior earnings history has been erratic and below guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
JAH - NYSE - CONSUMER NON-DURABLES - Rubber & Plastics Jarden Corp	$48.60	+0.96 2.02%	$48.61	$48.61	-0.02%	507,199 70.38%	720,700
Most Recent Note for JAH - 8/7/2012 12:32:20 PM Hitting another new 52-week high with today's 4th consecutive gain. Reported earnings +28% on +0% sales for the Jun '12 quarter. Found support when recently consolidating near prior highs in the $43 area and tallied additional volume-driven gains since noted in the 7/18/12 mid-day report - "Fundamentals are below the fact-based investment system's guidelines. It survived but failed to impress since noted in the 5/15/07 mid-day report."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MCC - NYSE - MATERIALS & CONSTRUCTION - General Building Materials Medley Capital Corp	$12.80	-0.03 -0.23%	$12.92	$13.00	-1.54%	101,947 69.59%	146,500
Most Recent Note for MCC - 8/7/2012 12:33:25 PM Holding its ground since an 8/03/12 gap up and volume-driven rally for new 52-week and all-time highs. Prior mid-day reports noted - "Earnings history is not a match with the winning models of the fact-based system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MDAS - NASDAQ - COMPUTER SOFTWARE & SERVICES - Healthcare Information Service Medassets Inc	$15.92	-0.01 -0.06%	$16.16	$16.16	-1.49%	403,627 84.11%	479,900
Most Recent Note for MDAS - 8/7/2012 12:34:32 PM Holding its ground and edging higher today after a considerable gap up and volume-driven gains for new 52-week highs noted last week. Reported earnings +22% on +11% sales revenues for the Jun '12 quarter, below the +25% guidelines, raising fundamental concerns.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
RMD - NYSE - HEALTH SERVICES - Medical Appliances & Equipment Resmed Inc	$36.17	+0.88 2.49%	$36.20	$36.20	-0.08%	946,083 104.00%	909,700
Most Recent Note for RMD - 8/7/2012 12:35:25 PM Holding its ground following a considerable gap up gain on 8/03/12, now perched near 52-week and multi-year highs with no resistance remaining. Reported +29% and +38% earnings for the Mar and Jun '12 quarterly comparisons versus the year ago periods, above the +25% minimum guideline. The prior 5 quarterly comparisons showed sub par earnings increases and its sales revenues growth has been in the +9-12% range. Its annual earnings (A criteria) growth history has been strong since a downturn in FY '08.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ROP - NYSE - MANUFACTURING - Diversified Machinery Roper Industries Inc	$103.50	+0.23 0.22%	$104.13	$108.89	-4.95%	334,691 64.46%	519,200
Most Recent Note for ROP - 8/7/2012 12:39:09 PM Consolidating near its 52-week high. Reported earnings +12% on +4% sales revenues for the quarter ended June 30, 2012 versus the year ago period. That marked 3 consecutive quarterly comparisons with earnings increases below the +25% minimum guideline (missing the C criteria). Its annual earnings (A criteria) history is below the fact-based system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
USNA - NYSE - DRUGS - Drug Related Products U S A N A Health Science	$44.93	-1.63 -3.50%	$47.56	$47.56	-5.53%	159,252 150.24%	106,000
Most Recent Note for USNA - 8/7/2012 12:40:37 PM Hit a new 52-week high today and then reversed into the red. Extended from prior highs in the $41-42 area after a streak of gains with above average volume. Reported earnings +35% on +8% sales revenues for the quarter ended June 30, 2012 versus the year ago period. Found support near its 50 DMA line since noted in the 5/01/12 mid-day report following a damaging gap down - "This network marketer of dietary supplements, health foods, and skin care products has been showing recent improvement in quarterly comparisons through Mar '12, but fundamentally the C criteria is not satisfied. Its annual earnings (A criteria) growth rate has been improving since a downturn in FY '08."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VASC - NASDAQ - HEALTH SERVICES - Medical Instruments & Supplies Vascular Solutions	$14.00	+0.02 0.14%	$14.05	$14.12	-0.85%	70,429 119.98%	58,700
Most Recent Note for VASC - 8/7/2012 12:41:22 PM Hovering near its 52-week high today after a spurt of volume-driven gains. Prior mid-day reports noted - "Fundamentals are still not a match with the fact-based investment system's guidelines. Reported earnings +15% on +11% sales revenues for the Jun '12 quarter. Survived but failed to impress since noted in the 8/08/11 mid-day report - 'Gapped down today, pulling back from its 52-week high hit last week. Annual earnings (A criteria) history has been good. The 2 latest quarterly comparisons versus the year ago period showed sales revenues increases in the +14-17% range with earnings per share increases in the +25-44% range. Ownership by top-rated funds fell from 124 in Dec '10 to 116 in Jun '11, whereas increasing institutional interest (I criteria) is clearly desired.'"
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
WIBC - NASDAQ - BANKING - Savings & Loans Wilshire Bancorp Inc	$6.54	+0.09 1.40%	$6.54	$6.55	-0.15%	299,436 63.53%	471,300
Most Recent Note for WIBC - 8/7/2012 12:44:11 PM Quarterly and annual earnings history is not a match with the fact-based investment system's guidelines. It survived but failed to impress since last noted on 12/12/06 when this stock was dropped from the Featured Stocks list.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.